India Infusion Pumps Market: By Product Type (Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia (PCA) Pumps, Pump Accessories), By Specialty (Chemotherapy, Gastroenterology, Analgesia/Pain Management, Pediatrics, Neonatology, Hematology, Others), and By End User (Corporate Hospitals, Tier I Hospitals, Tier II Hospitals, Government Hospitals, Others) and Forecast to 2030

Purchase Option

$ 3100
$ 4600
$ 6900

India Infusion Pumps Market was valued at USD 238.1 million in 2023 and is expected to grow at a 6.6% CAGR from 2024 to 2030. The increasing prevalence of surgical procedures in India, estimated at approximately 30 million annually, emphasize the critical role of infusion pumps within the healthcare ecosystem. These india infusion pumps are indispensable devices utilized to deliver medications, fluids, and nutrients to patients during surgical interventions, ensuring precise and controlled administration. Interestingly, the distribution of surgical procedures across different types of healthcare facilities in India highlights the widespread demand for infusion pumps. With 85% of surgeries occurring in smaller and mid-size hospitals, there exists a substantial need for infusion pump technology across a diverse range of healthcare settings. This indicates that india infusion pumps are not only essential in large corporate hospitals but also in smaller healthcare facilities, reflecting the broad spectrum of healthcare needs across the country.

Furthermore, projections based on studies estimating the age-adjusted requirement for surgeries in India suggest a staggering demand for approximately 50 million surgeries annually. This significant volume emphasizes the critical role infusion pumps play in supporting surgical interventions and ensuring optimal patient care outcomes. A recent study indicated an age-adjusted requirement of 3,646 surgeries per 100,000 Indian population annually, with one-third of these surgeries needed for individuals aged 30–49 years. Extrapolating from this study, India's surgical demand is projected to approach nearly 50 million procedures annually, illustrating the substantial need for infusion pumps to support medication administration during surgical interventions. Therefore, the rising demand for infusion pumps in India is intricately linked to the increasing volume of surgical procedures, reflecting the vital role these devices play in supporting surgical interventions. 

India Infusion Pumps Market Key Developments:
  • In May 2024, Baxter International Inc. a pioneer in infusion therapies and technologies, has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) featuring Dose IQ Safety Software. This clearance marks a pivotal moment for Baxter as it expands the Novum IQ Infusion Platform to include the LVP modality, complementing Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software and powered by the IQ Enterprise Connectivity Suite.
  • In December 2023, Fresenius Kabi announced a groundbreaking multiyear agreement with the prestigious Mayo Clinic, signaling a significant milestone in the healthcare industry. Under this agreement, the Mayo Clinic plans to acquire 10,000 units of the innovative Ivenix large-volume infusion pumps for its hospitals and clinics located in Minnesota, Arizona, and Florida.

India Infusion Pumps Market Dynamics

In India, despite considerable progress in reducing newborn mortality, challenges persist, particularly in addressing preventable deaths among newborns. Prematurity and low birth weight, birth asphyxia, neonatal pneumonia, and non-communicable diseases remain significant contributors to newborn deaths. According to recent statistics, nearly 3.5 million babies in India are born too early, with one million newborns discharged each year from special newborn care units (SNCUs), remaining at high risk of death, stunting, and developmental delay. Prematurity and low birth weight account for 48% of newborn deaths in babies less than 29 days old. Birth asphyxia and birth trauma contribute to 13% of neonatal deaths. Moreover, access to skilled birth attendants and emergency health services during and after delivery is crucial in preventing these deaths. The increase in institutional deliveries has been notable, with nine out of ten women now delivering in health facilities. However, the quality of service delivery needs improvement to match the increase in coverage. Early initiation of breastfeeding and addressing stillbirths are areas that require attention, reflecting the need for higher-quality healthcare services. There lies an opportunity for the Indian infusion pumps market to contribute to improving newborn healthcare outcomes. By enhancing access to advanced medical technologies, including syringe infusion pumps equipped with features to address neonatal care needs, such as precise medication delivery and safety protocols, healthcare facilities can better cater to the needs of newborns and their mothers. Moreover, focusing on innovative solutions tailored to address the specific challenges faced by marginalized communities, including access to remote and hard-to-reach areas, can further drive improvements in newborn healthcare outcomes. By leveraging technology and addressing systemic challenges, the Indian infusion pumps market play a vital role in advancing newborn healthcare and reducing preventable deaths, particularly among the most vulnerable populations. The future growth of the neonatal diseases is likely to remain significant and will drive the India infusion pumps market in the upcoming years

India Infusion Pumps Market Segmentation

By Product Type
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient Controlled Analgesia (PCA) Pumps
  • Pump Accessories
By Speciality
  • Chemotherapy
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics
  • Neonatology
  • Hematology
  • Others
By End User
  • Corporate Hospitals
  • Tier I Hospitals
  • Tier II Hospitals
  • Government Hospitals
  • Others

Frequently Asked Questions

The infusion pumps market was valued at USD 238.1 million in 2023 and is expected to grow at a 6.6% CAGR from 2024 to 2030.

Transforming patient care through telemedicine-integrated infusion pumps, addressing challenges in new-born healthcare, advancement in software technology are expected to provide opportunities to the market players in the market growth over the forecast period.

The leading players in the India infusion pumps market are Baxter International, Fresenius Kabi, ICU Medical, Becton, Dickinson and Company, B.Braun and others

The india infusion pumps market is segmented based on product type, specialty, and end user.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario.
1. Executive Summary
2.  India Infusion Pumps Market Introduction 
2.1. India Infusion Pumps Market   - Taxonomy
2.2. India Infusion Pumps Market   - Definitions
2.2.1. Product Type
2.2.2. Specialty
2.2.3. End User
3. India Infusion Pumps Market Dynamics
3.1. India Infusion Pumps Market - Macro-Economics Factors
3.2. India Infusion Pumps Market Dynamic Factors - Impact Analysis
3.3. India Infusion Pumps Market Dynamic Factors – Market Background
3.3.1. Drivers and Restraints
3.3.2. Opportunities/Unmet Needs of the Market & Trends
3.4. Value Added Insights (USPs)
4. India Infusion Pumps Market Demand (in Value or Size in US$ Mn) Analysis 2022–2023 and Forecast, 2024–2030
5. India Infusion Pumps Market By Product Type, 2022-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. Volumetric Infusion Pumps
5.1.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Syringe Infusion Pumps
5.2.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Ambulatory Infusion Pumps
5.3.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Patient Controlled Analgesia (PCA) Pumps
5.4.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Pump Accessories
5.5.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6. India Infusion Pumps Market By Specialty, 2022-2023 and Forecast 2024-2030 (Sales Value USD Million)
6.1. Chemotherapy 
6 1 1  Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.2. Gastroenterology 
6.2.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Analgesia/Pain Management
6.3.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Pediatrics
6.4.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Neonatology
6.5.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Hematology
6.6.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.  India Infusion Pumps Market  By End User, 2022-2023 and Forecast 2024-2030 (Sales Value USD Million)
7.1. Corporate Hospitals
7.1.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Tier I Hospitals
7.2.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Tier II Hospitals
7.3.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Government Hospitals
7.4.1. Market Analysis, 2022-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.  Competition Landscape
8.1. Company Share Analysis (2023)
8.2. Strategic Dashboard of Top Market Players
8.3. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
8.3.1. Baxter International
8.3.2. Fresenius Kabi
8.3.3. ICU Medical
8.3.4. Becton, Dickinson and Company 
8.3.5. B.Braun
8.3.6. AKAS Infusions
8.3.7. Allied Medical Limited
8.3.8. Narang Medical Limited
8.3.9. Plenum Tech Private Limited
8.3.10. GPC Medical Ltd.
8.3.11. Skanray Technologies Limited
8.3.12. BPL Medical Technologies
8.3.13. Mindray Medical India Pvt. Ltd.
8.3.13. Medion
8.3.13. Nidek Medical India
8.3.13. Mais India
9.  Research Methodology
10.  Key Assumptions and Acronyms
  • Baxter International
  • Fresenius Kabi
  • ICU Medical
  • Becton, Dickinson and Company
  • B.Braun
  • AKAS Infusions
  • Allied Medical Limited
  • Narang Medical Limited
  • Plenum Tech Private Limited
  • GPC Medical Ltd
  • Skanray Technologies Limited
  • BPL Medical Technologies
  • Mindray Medical India Pvt. Ltd
  • Medion
  • Nidek Medical India
  • Mais India

Adjacent Markets